OtherBASIC SCIENCE INVESTIGATIONS
In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice
Douglas W. Schneider, Tara Heitner, Bruno Alicke, David R. Light, Kirk McLean, Noboru Satozawa, Gordon Parry, Jeongsoo Yoo, Jason S. Lewis and Renate Parry
Journal of Nuclear Medicine March 2009, 50 (3) 435-443; DOI: https://doi.org/10.2967/jnumed.108.055608
Douglas W. Schneider
Tara Heitner
Bruno Alicke
David R. Light
Kirk McLean
Noboru Satozawa
Gordon Parry
Jeongsoo Yoo
Jason S. Lewis

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 50, Issue 3
March 2009
In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice
Douglas W. Schneider, Tara Heitner, Bruno Alicke, David R. Light, Kirk McLean, Noboru Satozawa, Gordon Parry, Jeongsoo Yoo, Jason S. Lewis, Renate Parry
Journal of Nuclear Medicine Mar 2009, 50 (3) 435-443; DOI: 10.2967/jnumed.108.055608
In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice
Douglas W. Schneider, Tara Heitner, Bruno Alicke, David R. Light, Kirk McLean, Noboru Satozawa, Gordon Parry, Jeongsoo Yoo, Jason S. Lewis, Renate Parry
Journal of Nuclear Medicine Mar 2009, 50 (3) 435-443; DOI: 10.2967/jnumed.108.055608
Jump to section
Related Articles
Cited By...
- Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives
- Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody
- Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer
- Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment